<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>From Linear Probing to Joint-Weighted Token Hierarchy: A Foundation Model Bridging Global and Cellular Representations in Biomarker Detection - Health AI Hub</title>
    <meta name="description" content="This paper introduces JWTH (Joint-Weighted Token Hierarchy), a novel pathology foundation model designed to bridge global patch-level and cellular-level represe">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>From Linear Probing to Joint-Weighted Token Hierarchy: A Foundation Model Bridging Global and Cellular Representations in Biomarker Detection</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.05150v1" target="_blank">2511.05150v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-07
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Jingsong Liu, Han Li, Nassir Navab, Peter J. Sch√ºffler
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.05150v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.05150v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces JWTH (Joint-Weighted Token Hierarchy), a novel pathology foundation model designed to bridge global patch-level and cellular-level representations for improved AI-based biomarker detection. By integrating self-supervised pretraining, cell-centric post-tuning, and attention pooling, JWTH achieves superior balanced accuracy and robustness compared to prior models across multiple biomarker tasks and cohorts.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research significantly enhances the capability of AI to infer molecular features directly from standard H&E stained pathology slides, offering a faster and potentially more cost-effective method for biomarker detection crucial for disease diagnosis, prognosis, and guiding personalized treatment strategies.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI model (JWTH) is designed to improve the detection of biomarkers from H&E stained tissue slides, providing more accurate and interpretable insights into molecular features. This directly applies to enhancing medical diagnostics, aiding in disease prognosis, and potentially guiding treatment decisions by leveraging AI in digital pathology workflows.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses a critical limitation in existing pathology foundation models (PFMs) which primarily rely on global patch-level embeddings, often overlooking crucial cell-level morphology in H&E slides.</li>
                    
                    <li>Introduces JWTH (Joint-Weighted Token Hierarchy), a new PFM that explicitly integrates both global and cellular representations.</li>
                    
                    <li>JWTH's methodology combines large-scale self-supervised pretraining for general feature learning with cell-centric post-tuning to specifically enhance cell-level morphological understanding.</li>
                    
                    <li>Employs attention pooling mechanisms to effectively fuse local (cell-level) and global (patch-level) tokens, creating a comprehensive hierarchical representation.</li>
                    
                    <li>Evaluated rigorously across four distinct biomarker detection tasks, involving four different biomarkers and eight diverse patient cohorts.</li>
                    
                    <li>Demonstrates significant performance improvements, achieving up to 8.3% higher balanced accuracy and an average improvement of 1.2% over prior PFMs.</li>
                    
                    <li>The model contributes to more interpretable and robust AI-based biomarker detection, which is crucial for clinical applications in digital pathology.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>JWTH is a Pathology Foundation Model built upon a hierarchical token architecture. It leverages large-scale self-supervised pretraining to learn robust visual features from H&E slides. This is complemented by a cell-centric post-tuning phase that specifically refines the model's understanding of cellular morphology. The core innovation lies in its attention pooling mechanism, which dynamically fuses fine-grained local (cell-level) tokens with broader global (patch-level) tokens, creating a rich, multi-scale representation for biomarker inference.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The JWTH model achieves notable advancements in AI-based biomarker detection, demonstrating an improvement of up to 8.3% in balanced accuracy and an average improvement of 1.2% compared to existing Pathology Foundation Models. These results were consistent across evaluations involving four different biomarker detection tasks, four distinct biomarkers, and eight diverse patient cohorts, indicating enhanced robustness and generalization capability.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>JWTH offers a more accurate and robust AI tool for inferring molecular biomarkers directly from widely available H&E slides, bypassing the need for expensive and time-consuming specialized molecular tests in some cases. This could lead to quicker, more precise diagnoses, better patient stratification for targeted therapies, and improved prognostication, particularly in oncology, thereby advancing personalized medicine and patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any specific limitations of the JWTH model or the study's scope.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly suggest future research directions for the JWTH model or its applications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Digital Pathology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Molecular Diagnostics</span>
                    
                    <span class="tag">Histopathology</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">AI-based biomarkers</span>
                    
                    <span class="tag tag-keyword">Digital Pathology</span>
                    
                    <span class="tag tag-keyword">Foundation Models</span>
                    
                    <span class="tag tag-keyword">H&E slides</span>
                    
                    <span class="tag tag-keyword">Cell-level morphology</span>
                    
                    <span class="tag tag-keyword">Self-supervised learning</span>
                    
                    <span class="tag tag-keyword">Attention pooling</span>
                    
                    <span class="tag tag-keyword">Molecular features</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">AI-based biomarkers can infer molecular features directly from hematoxylin &
eosin (H&E) slides, yet most pathology foundation models (PFMs) rely on global
patch-level embeddings and overlook cell-level morphology. We present a PFM
model, JWTH (Joint-Weighted Token Hierarchy), which integrates large-scale
self-supervised pretraining with cell-centric post-tuning and attention pooling
to fuse local and global tokens. Across four tasks involving four biomarkers
and eight cohorts, JWTH achieves up to 8.3% higher balanced accuracy and 1.2%
average improvement over prior PFMs, advancing interpretable and robust
AI-based biomarker detection in digital pathology.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>